Big Pharma Suffers Major Blow: Study Says Treating High Cholesterol With Statins Is a Waste of Time

by DailyHealthPost Editorial

statin drugs worthless

Some scientists even suggest that if the “good and bad” cholesterol theory were actually correct, people with high LDL cholesterol would all be more atherosclerotic than those with low HDL cholesterol, but the truth is…they aren’t. (6,7,8,9)


In fact, one recent and very large review published in the BMJ Open journal involving close to 70,000 people further concludes there is no link between “bad” cholesterol and the premature deaths of people over 60 from cardiovascular disease. (10)

The authors of the study go so far as to state, “…older people with high LDL (low-density lipoprotein) levels, the so-called “bad” cholesterol, lived longer and had less heart disease.” (11)


So why do doctors continue to paint LDL cholesterol as the ultimate villain? The answer is actually quite simple—Big Pharma.

A $100 Billion Industry

Statin drugs — including such medications as atorvastatin (Lipitor), simvastatin (Zocor), and others—are the most widely prescribed drugs of all time. (12)

The only reason the “good and bad” cholesterol theory continues is that it is in the best interest of wealthy pharmaceutical companies to continue selling these drugs that amount to approximately $100 billion a year in sales.


Lipitor alone has made $140 billion since it was first introduced, making it the most profitable dug of all time. (13)

While those numbers are astounding in and of themselves, if big pharma has anything to do with it those numbers will double if not triple by 2030. (14)